Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Extracellular Matrix Abnormalities in the Hippocampus of Subjects with Substance Use Disorder

Jake Valeri, Charlotte Stiplosek, Sinead M. O’Donovan, David Sinclair, Kathleen Grant, Ratna Bollavarapu, Donna M. Platt, Craig A. Stockmeier, Barbara Gisabella, Harry Pantazopoulos
doi: https://doi.org/10.1101/2023.09.07.23295222
Jake Valeri
aDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS
bProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Stiplosek
aDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sinead M. O’Donovan
cDepartment of Neuroscience, University of Toledo, Toledo, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Sinclair
cDepartment of Neuroscience, University of Toledo, Toledo, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen Grant
dOregon Primate Research Center, Hillsboro, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ratna Bollavarapu
bProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna M. Platt
aDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS
bProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig A. Stockmeier
aDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS
bProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Gisabella
aDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS
bProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harry Pantazopoulos
aDepartment of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS
bProgram in Neuroscience, University of Mississippi Medical Center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cpantazopoulos{at}umc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Contextual triggers are significant factors contributing to relapse in substance use disorders (SUD). Emerging evidence points to a critical role of extracellular matrix (ECM) molecules as mediators of reward memories. Chondroitin sulfate proteoglycans (CSPGs) are a subset of ECM molecules that form perineuronal nets (PNN) around inhibitory neurons. PNNs restrict synaptic connections and help maintain synapses. Rodent models suggest that modulation of PNNs may strengthen contextual reward memories in SUD. However, there is currently a lack of information regarding PNNs in the hippocampus of people with SUD as well as how comorbidity with major depressive disorder (MDD) may affect PNNs. We used postmortem hippocampal tissues from cohorts of human and nonhuman primates with or without chronic alcohol use to test the hypothesis that PNNs are increased in subjects with SUD. We used histochemical labeling and quantitative microscopy to examine PNNs, and qRT-PCR to examine gene expression for ECM molecules, synaptic markers and related markers. We identified increased densities of PNNs and CSPG-labeled glial cells in SUD, coinciding with decreased expression of the ECM protease matrix metalloproteinase 9 (Mmp9), and increased expression for the excitatory synaptic marker vesicle associated membrane protein 2 (Vamp2). Similar increases in PNNs were observed in monkeys with chronic alcohol self-administration. Subjects with MDD displayed changes opposite to SUD, and subjects with SUD and comorbid MDD had minimal changes in any of the outcome measures examined. Our findings demonstrate that PNNs are increased in SUD, possibly contributing to stabilizing contextual reward memories as suggested by preclinical studies. Our results also point to a previously unsuspected role for CSPG expression in glial cells in SUD. Evidence for increased hippocampal PNNs in SUD suggests that targeting PNNs to weaken contextual reward memories is a promising therapeutic approach for SUD, however comorbidity with MDD is a significant consideration.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by support from the National Institute of Mental Health (R01 MH125833 and R01 MH117460), the National Institute of Alcoholism and Alcohol Abuse (P60AA010760, R24AA019431, F31 AA030166 and R01 AA029023), National Institute of Health (P51OD011092) and the Postmortem Brain Core of the Center for Psychiatric Neuroscience, funded through an IDeA COBRE award from the National Institute of General Medical Sciences (P30 GM103328).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Institutional Review Boards of the University of Mississippi Medical Center, Jackson, MS and the University Hospitals Cleveland Medical Center, Cleveland, OH gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • The manuscript has been revised to update the figures, results section, introduction, and discussion.

Data Availability Statement

The data and original contributions presented in this study are included in the manuscript or supplemental materials. Further inquiries can be directed to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 02, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Extracellular Matrix Abnormalities in the Hippocampus of Subjects with Substance Use Disorder
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Extracellular Matrix Abnormalities in the Hippocampus of Subjects with Substance Use Disorder
Jake Valeri, Charlotte Stiplosek, Sinead M. O’Donovan, David Sinclair, Kathleen Grant, Ratna Bollavarapu, Donna M. Platt, Craig A. Stockmeier, Barbara Gisabella, Harry Pantazopoulos
medRxiv 2023.09.07.23295222; doi: https://doi.org/10.1101/2023.09.07.23295222
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Extracellular Matrix Abnormalities in the Hippocampus of Subjects with Substance Use Disorder
Jake Valeri, Charlotte Stiplosek, Sinead M. O’Donovan, David Sinclair, Kathleen Grant, Ratna Bollavarapu, Donna M. Platt, Craig A. Stockmeier, Barbara Gisabella, Harry Pantazopoulos
medRxiv 2023.09.07.23295222; doi: https://doi.org/10.1101/2023.09.07.23295222

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)